Browsing by Author "Lorusso, Domenica"
Now showing items 1-6 of 6
-
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
Lorusso, Domenica; Ray-Coquard, Isabelle; Oaknin benzaquen, Ana Mazaltob; Banerjee, Susana (BMJ, 2020-10-13) -
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Banerjee, Susana; Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin benzaquen, Ana Mazaltob (BMJ, 2020-12-11) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta (Wiley, 2021-10) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta (American Society of Clinical Oncology, 2020-10-20) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Colombo, Nicoletta; Oaknin benzaquen, Ana Mazaltob; Scambia, Giovanni; Lorusso, Domenica (Elsevier, 2021-06) -
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Colombo, Nicoletta; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin benzaquen, Ana Mazaltob; Dean, Andrew (Elsevier, 2020-10-01)